September 24, 2021FALSE0000042888--12-31169,965,5762021Q313,321——13,32100000428882020-12-262021-09-24xbrli:shares00000428882021-10-13iso4217:USD00000428882021-06-262021-09-2400000428882020-06-272020-09-2500000428882019-12-282020-09-25iso4217:USDxbrli:shares00000428882021-09-2400000428882020-12-2500000428882019-12-2700000428882020-09-250000042888us-gaap:CommonStockMember2021-06-250000042888us-gaap:AdditionalPaidInCapitalMember2021-06-250000042888us-gaap:RetainedEarningsMember2021-06-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-2500000428882021-06-250000042888us-gaap:CommonStockMember2021-06-262021-09-240000042888us-gaap:AdditionalPaidInCapitalMember2021-06-262021-09-240000042888us-gaap:RetainedEarningsMember2021-06-262021-09-240000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-262021-09-240000042888us-gaap:CommonStockMember2021-09-240000042888us-gaap:AdditionalPaidInCapitalMember2021-09-240000042888us-gaap:RetainedEarningsMember2021-09-240000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-240000042888us-gaap:CommonStockMember2020-12-250000042888us-gaap:AdditionalPaidInCapitalMember2020-12-250000042888us-gaap:RetainedEarningsMember2020-12-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-250000042888us-gaap:CommonStockMember2020-12-262021-09-240000042888us-gaap:AdditionalPaidInCapitalMember2020-12-262021-09-240000042888us-gaap:RetainedEarningsMember2020-12-262021-09-240000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-262021-09-240000042888us-gaap:CommonStockMember2020-06-260000042888us-gaap:AdditionalPaidInCapitalMember2020-06-260000042888us-gaap:RetainedEarningsMember2020-06-260000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-2600000428882020-06-260000042888us-gaap:CommonStockMember2020-06-272020-09-250000042888us-gaap:AdditionalPaidInCapitalMember2020-06-272020-09-250000042888us-gaap:RetainedEarningsMember2020-06-272020-09-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-272020-09-250000042888us-gaap:CommonStockMember2020-09-250000042888us-gaap:AdditionalPaidInCapitalMember2020-09-250000042888us-gaap:RetainedEarningsMember2020-09-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-250000042888us-gaap:CommonStockMember2019-12-270000042888us-gaap:AdditionalPaidInCapitalMember2019-12-270000042888us-gaap:RetainedEarningsMember2019-12-270000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-270000042888us-gaap:CommonStockMember2019-12-282020-09-250000042888us-gaap:AdditionalPaidInCapitalMember2019-12-282020-09-250000042888us-gaap:RetainedEarningsMember2019-12-282020-09-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-282020-09-25ggg:segment0000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2021-06-262021-09-240000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2020-06-272020-09-250000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2020-12-262021-09-240000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2019-12-282020-09-250000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2021-06-262021-09-240000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2020-06-272020-09-250000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2020-12-262021-09-240000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2019-12-282020-09-250000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2021-06-262021-09-240000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2020-06-272020-09-250000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2020-12-262021-09-240000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2019-12-282020-09-250000042888us-gaap:CorporateNonSegmentMember2021-06-262021-09-240000042888us-gaap:CorporateNonSegmentMember2020-06-272020-09-250000042888us-gaap:CorporateNonSegmentMember2020-12-262021-09-240000042888us-gaap:CorporateNonSegmentMember2019-12-282020-09-250000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2021-09-240000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2020-12-250000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2021-09-240000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2020-12-250000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2021-09-240000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2020-12-250000042888us-gaap:CorporateNonSegmentMember2021-09-240000042888us-gaap:CorporateNonSegmentMember2020-12-250000042888country:US2021-06-262021-09-240000042888country:US2020-06-272020-09-250000042888country:US2020-12-262021-09-240000042888country:US2019-12-282020-09-250000042888us-gaap:NonUsMember2021-06-262021-09-240000042888us-gaap:NonUsMember2020-06-272020-09-250000042888us-gaap:NonUsMember2020-12-262021-09-240000042888us-gaap:NonUsMember2019-12-282020-09-250000042888country:US2021-09-240000042888country:US2020-12-250000042888us-gaap:NonUsMember2021-09-240000042888us-gaap:NonUsMember2020-12-250000042888us-gaap:EmployeeStockOptionMember2020-12-262021-09-240000042888us-gaap:EmployeeStockOptionMember2019-12-282020-09-25xbrli:pure0000042888us-gaap:EmployeeStockMember2020-12-262021-09-240000042888us-gaap:EmployeeStockMember2019-12-282020-09-250000042888us-gaap:PensionPlansDefinedBenefitMember2021-06-262021-09-240000042888us-gaap:PensionPlansDefinedBenefitMember2020-06-272020-09-250000042888us-gaap:PensionPlansDefinedBenefitMember2020-12-262021-09-240000042888us-gaap:PensionPlansDefinedBenefitMember2019-12-282020-09-250000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-06-262021-09-240000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-06-272020-09-250000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-262021-09-240000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-282020-09-25ggg:numberOfParticipants0000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2021-06-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-262021-09-240000042888us-gaap:AccumulatedTranslationAdjustmentMember2021-06-262021-09-240000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-240000042888us-gaap:AccumulatedTranslationAdjustmentMember2021-09-240000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-12-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-262021-09-240000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-12-262021-09-240000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-260000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-06-260000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-272020-09-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-06-272020-09-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-09-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-270000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-12-270000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-282020-09-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-12-282020-09-250000042888us-gaap:CustomerRelationshipsMember2021-09-240000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2021-09-240000042888us-gaap:TrademarksAndTradeNamesMember2021-09-240000042888us-gaap:TradeNamesMember2021-09-240000042888us-gaap:CustomerRelationshipsMember2020-12-262021-09-240000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2020-12-262021-09-240000042888us-gaap:TrademarksAndTradeNamesMember2020-12-262021-09-240000042888us-gaap:TradeNamesMember2020-12-262021-09-240000042888us-gaap:CustomerRelationshipsMember2020-12-250000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2020-12-250000042888us-gaap:TrademarksAndTradeNamesMember2020-12-250000042888us-gaap:TradeNamesMember2020-12-250000042888us-gaap:CustomerRelationshipsMember2019-12-282020-12-250000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2019-12-282020-12-250000042888us-gaap:TrademarksAndTradeNamesMember2019-12-282020-12-250000042888us-gaap:TradeNamesMember2019-12-282020-12-2500000428882019-12-282020-12-250000042888ggg:IndustrialMember2020-12-250000042888ggg:ProcessMember2020-12-250000042888ggg:ContractorMember2020-12-250000042888ggg:IndustrialMember2020-12-262021-09-240000042888ggg:ProcessMember2020-12-262021-09-240000042888ggg:ContractorMember2020-12-262021-09-240000042888ggg:IndustrialMember2021-09-240000042888ggg:ProcessMember2021-09-240000042888ggg:ContractorMember2021-09-240000042888ggg:CommittedFacilityMember2021-09-240000042888us-gaap:RevolvingCreditFacilityMemberggg:CommittedFacilityMember2021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberggg:CommittedFacilityMember2021-06-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberggg:CommittedFacilityMember2021-06-262021-09-240000042888us-gaap:FederalFundsEffectiveSwapRateMemberus-gaap:LineOfCreditMemberggg:CommittedFacilityMember2021-06-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:LondonInterbankOfferedRateLIBORMemberggg:CommittedFacilityMember2021-06-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMemberggg:CommittedFacilityMember2021-06-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberggg:CommittedFacilityMember2021-06-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberggg:CashFlowLeverageRatioNoAcquisitionMembersrt:MaximumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberggg:CashFlowLeverageRatioNoAcquisitionMembersrt:MinimumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberggg:CashFlowLeverageRatioWithAcquisitionsMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberggg:CashFlowLeverageRatioWithAcquisitionsMembersrt:MinimumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberggg:InterestCoverageRatioNoAcquisitionsMembersrt:MaximumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberggg:InterestCoverageRatioNoAcquisitionsMembersrt:MinimumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberggg:InterestCoverageRatioWithAcquisitionsMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberggg:InterestCoverageRatioWithAcquisitionsMembersrt:MinimumMemberggg:CommittedFacilityMember2020-12-262021-09-240000042888us-gaap:FairValueInputsLevel2Member2021-09-240000042888us-gaap:FairValueInputsLevel2Member2020-12-250000042888us-gaap:FairValueInputsLevel3Member2021-09-240000042888us-gaap:FairValueInputsLevel3Member2020-12-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
For the quarterly period ended September 24, 2021
☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from to
Commission File Number: 001-09249
GRACO INC.
(Exact name of registrant as specified in its charter)
Minnesota
41-0285640
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification Number)
88 - 11th Avenue N.E.
Minneapolis,
Minnesota
55413
(Address of principal executive offices)
(Zip Code)
(612)
623-6000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $1.00 per share
GGG
The New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
169,965,576 shares of the Registrant’s Common Stock, $1.00 par value, were outstanding as of October 13, 2021.
The consolidated balance sheet of Graco Inc. and subsidiaries (the “Company”) as of September 24, 2021 and the related statements of earnings, comprehensive income and shareholders' equity for the three and nine months ended September 24, 2021 and September 25, 2020, and cash flows for the nine months ended September 24, 2021 and September 25, 2020 have been prepared by the Company and have not been audited.
In the opinion of management, these consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of the Company as of September 24, 2021, and the results of operations and cash flows for all periods presented.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Company’s 2020 Annual Report on Form 10-K.
The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year.
2.Segment Information
The Company has three reportable segments: Industrial, Process and Contractor. Sales and operating earnings by segment were as follows (in thousands):
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
Three Months Ended
Nine Months Ended
September 24, 2021
September 25, 2020
September 24, 2021
September 25, 2020
Net earnings available to common shareholders
$
103,829
$
114,115
$
319,634
$
215,765
Weighted average shares outstanding for basic earnings per share
169,834
167,102
169,459
167,248
Dilutive effect of stock options computed using the treasury stock method and the average market price
4,940
4,551
4,939
4,367
Weighted average shares outstanding for diluted earnings per share
174,774
171,653
174,398
171,615
Basic earnings per share
$
0.61
$
0.68
$
1.89
$
1.29
Diluted earnings per share
$
0.59
$
0.66
$
1.83
$
1.26
Stock options to purchase 428,000 and 1,281,000 shares were not included in the September 24, 2021 and September 25, 2020 computations of diluted earnings per share, respectively, because they would have been anti-dilutive.
4.Share-Based Awards
Options on common shares granted and outstanding, as well as the weighted average exercise price, are shown below (in thousands, except exercise prices):
Option Shares
Weighted Average Exercise Price
Options Exercisable
Weighted Average Exercise Price
Outstanding, December 25, 2020
10,208
$
35.02
6,553
$
28.02
Granted
841
72.21
Exercised
(958)
23.28
Canceled
(131)
54.75
Outstanding, September 24, 2021
9,960
$
39.03
7,627
$
33.49
The Company recognized year-to-date share-based compensation of $19.9 million in 2021 and $21.4 million in 2020. As of September 24, 2021, there was $12.6 million of unrecognized compensation cost related to unvested options, expected to be recognized over a weighted average period of 2.7 years.
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions and results:
Nine Months Ended
September 24, 2021
September 25, 2020
Expected life in years
7.5
7.5
Interest rate
1.2
%
1.5
%
Volatility
25.3
%
22.0
%
Dividend yield
1.0
%
1.3
%
Weighted average fair value per share
$
18.91
$
12.18
Under the Company’s Employee Stock Purchase Plan, the Company issued 416,000 shares in 2021 and 400,000 shares in 2020. The fair value of the employees’ purchase rights under this Plan was estimated on the date of grant. The benefit of the 15 percentdiscount from the lesser of the fair market value per common share on the first day and the last day of the plan year was added to the fair value of the employees’ purchase rights determined using the Black-Scholes option-pricing model with the following assumptions and results:
The components of net periodic benefit cost for retirement benefit plans were as follows (in thousands):
Three Months Ended
Nine Months Ended
September 24, 2021
September 25, 2020
September 24, 2021
September 25, 2020
Pension Benefits
Service cost
$
1,674
$
2,392
$
7,119
$
7,007
Interest cost
2,519
3,351
8,476
9,985
Expected return on assets
(5,412)
(4,706)
(15,673)
(14,107)
Amortization and other
2,148
2,777
7,254
8,015
Net periodic benefit cost
$
929
$
3,814
$
7,176
$
10,900
Postretirement Medical
Service cost
$
153
$
152
$
503
$
457
Interest cost
124
254
624
762
Amortization
252
183
752
550
Net periodic benefit cost
$
529
$
589
$
1,879
$
1,769
Subsequent Event
Subsequent to the end of the third quarter, the Company entered into an agreement under which approximately $63 million of $414 million in pension obligations in its two U.S. funded defined benefit pension plans were transferred to an insurance company.
Under the agreement, the Company will purchase a group annuity contract for approximately 421 plan participants that will provide for an irrevocable commitment to make annuity payments to the affected participants. The payment obligation and administration thereof for the affected participants will be transferred from the pension plans to the insurance company. The transfer will not change the amount of the monthly pension benefits received by the affected participants. The smaller of the two pension plans will be merged into the larger plan in the fourth quarter of 2021, with the larger plan being the surviving plan.
This arrangement is part of the Company’s effort to reduce the overall size and volatility of its pension plan obligations. The purchase of the group annuity contract will be funded through existing plan assets. The Company expects to recognize a non-cash pension settlement loss of approximately $12 million before tax in the fourth quarter of 2021. This charge represents the acceleration of deferred charges currently accrued in accumulated other comprehensive income. The actual amount of the settlement loss will depend on the value of plan assets and the discount rate as of the measurement date.
Changes in components of accumulated other comprehensive income (loss), net of tax were as follows (in thousands):
Pension and Postretirement Medical
Cumulative Translation Adjustment
Total
Three Months Ended September 24, 2021
Balance, June 25, 2021
$
(109,655)
$
(14,813)
$
(124,468)
Other comprehensive income (loss) before reclassifications
—
(3,537)
(3,537)
Reclassified to pension cost and deferred tax
1,995
—
1,995
Balance, September 24, 2021
$
(107,660)
$
(18,350)
$
(126,010)
Nine Months Ended September 24, 2021
Balance, December 25, 2020
$
(114,129)
$
(10,036)
$
(124,165)
Other comprehensive income (loss) before reclassifications
—
(8,314)
(8,314)
Reclassified to pension cost and deferred tax
6,469
—
6,469
Balance, September 24, 2021
$
(107,660)
$
(18,350)
$
(126,010)
Three Months Ended September 25, 2020
Balance, June 26, 2020
$
(109,695)
$
(53,987)
$
(163,682)
Other comprehensive income (loss) before reclassifications
—
30,966
30,966
Reclassified to pension cost and deferred tax
1,801
—
1,801
Balance, September 25, 2020
$
(107,894)
$
(23,021)
$
(130,915)
Nine Months Ended September 25, 2020
Balance, December 27, 2019
$
(113,721)
$
(56,066)
$
(169,787)
Other comprehensive income (loss) before reclassifications
—
33,045
33,045
Reclassified to pension cost and deferred tax
5,827
—
5,827
Balance, September 25, 2020
$
(107,894)
$
(23,021)
$
(130,915)
Amounts related to pension and postretirement medical adjustments are reclassified to non-service components of pension cost that are included within other non-operating expenses.
Accounts receivable includes trade receivables of $316 million and other receivables of $9 million as of September 24, 2021 and $302 million and $13 million, respectively, as of December 25, 2020.
Allowance for Credit Losses
Following is a summary of activity in the year to date allowance for credit losses (in thousands):
September 24, 2021
September 25, 2020
Balance, beginning
$
3,745
$
4,828
Additions (reversals) charged to costs and expenses
164
338
Deductions from reserves (1)
(425)
(1,247)
Other additions (deductions) (2)
68
106
Balance, ending
$
3,552
$
4,025
(1) Represents amounts determined to be uncollectible and charged against reserves, net of collections on accounts previously charged against reserves.
(2) Includes amounts assumed or established in connection with acquisitions and effects of foreign currency translation.
8.Inventories
Major components of inventories were as follows (in thousands):
September 24, 2021
December 25, 2020
Finished products and components
$
165,771
$
133,122
Products and components in various stages of completion
Components of other intangible assets were as follows (dollars in thousands):
Finite Life
Indefinite Life
Customer Relationships
Patents and Proprietary Technology
Trademarks, Trade Names and Other
Trade Names
Total
As of September 24, 2021
Cost
$
194,505
$
26,074
$
900
$
62,633
$
284,112
Accumulated amortization
(104,892)
(15,023)
(414)
—
(120,329)
Foreign currency translation
(7,414)
(655)
—
(1,350)
(9,419)
Book value
$
82,199
$
10,396
$
486
$
61,283
$
154,364
Weighted average life in years
13
10
5
N/A
As of December 25, 2020
Cost
$
186,073
$
25,187
$
900
$
61,920
$
274,080
Accumulated amortization
(93,832)
(12,924)
(301)
—
(107,057)
Foreign currency translation
(6,004)
(538)
—
188
(6,354)
Book value
$
86,237
$
11,725
$
599
$
62,108
$
160,669
Weighted average life in years
13
10
5
N/A
Amortization of intangibles for the quarter was $4.6 million in 2021 and $4.2 million in 2020 and for the year to date was $13.4 million in 2021 and $12.5 million in 2020. Estimated annual amortization expense based on the current carrying amount of other intangible assets is as follows (in thousands):
2021 (Remainder)
2022
2023
2024
2025
Thereafter
Estimated Amortization Expense
$
4,646
$
17,757
$
16,980
$
15,425
$
14,853
$
23,420
Changes in the carrying amount of goodwill for each reportable segment were as follows (in thousands):
Components of other current liabilities were as follows (in thousands):
September 24, 2021
December 25, 2020
Accrued self-insurance retentions
$
8,111
$
8,041
Accrued warranty and service liabilities
14,139
13,082
Accrued trade promotions
14,035
12,140
Payable for employee stock purchases
11,522
14,554
Customer advances and deferred revenue
56,000
41,689
Income taxes payable
9,126
8,564
Right of return refund liability
19,001
16,303
Operating lease liabilities, current
9,409
11,178
Other
40,488
31,709
Total
$
181,831
$
157,260
A liability is established for estimated future warranty and service claims that relate to current and prior period sales. The Company estimates warranty costs based on historical claim experience and other factors including evaluating specific product warranty issues. Following is a summary of activity in accrued warranty and service liabilities (in thousands):
Balance, December 25, 2020
$
13,082
Assumed in business acquisition
24
Charged to expense
8,074
Margin on parts sales reversed
2,609
Reductions for claims settled
(9,650)
Balance, September 24, 2021
$
14,139
Deferred Revenue
Revenue is deferred when cash payments are received or due in advance of performance, including amounts which are refundable. This is also the case for services associated with certain product sales. The balance in the deferred revenue and customer advances was $56.0 million as of September 24, 2021 and $41.7 million as of December 25, 2020. Net sales for the year to date included $40.4 million in 2021 and $25.9 million in 2020 that related to deferred revenue as of the beginning of each period.
11.Debt
On March 25, 2021, the Company entered into an Amended and Restated Credit Agreement that amends, supersedes and restates in its entirety the Company's prior Credit Agreement with U.S. Bank National Association, as administrative agent (the “Agent”) and a lender, and the other lenders that are parties thereto. The Amended and Restated Credit Agreement extends the maturity of the Company’s $500 million unsecured revolving credit facility from December 15, 2021 to March 25, 2026; includes a $250 million accordion feature; and provides mechanisms for two further one-year extensions of the maturity, subject to the consent of the extending banks.
Borrowings under the Amended and Restated Credit Agreement may be denominated in U.S. Dollars or certain other currencies. Outstanding loans in currencies other than U.S. Dollars cannot exceed $200 million in the aggregate. Loans denominated in U.S. Dollars may bear interest, at the Company’s option, at either a base rate or a LIBOR-based rate. Loans denominated in currencies other than U.S. Dollars will bear interest at a LIBOR-based rate. The base rate is an annual rate equal to a margin ranging from 0.00% to 0.75%, depending on the Company’s cash flow leverage ratio, plus the highest of (i) the rate of interest from time to time announced by the Agent as its prime rate, (ii) the federal funds effective rate plus 0.50%, or (iii) one-month LIBOR plus 1.50%. In general, LIBOR-based loans bear interest at a rate per annum equal to LIBOR, plus a margin ranging from 1.00% to 1.75%, depending on the Company’s cash flow leverage ratio.
In addition to paying interest on the outstanding loans, the Company is required to pay a facility fee on the unused amount of the loan commitments at a rate per annum ranging from 0.125% to 0.25%, depending on the Company’s cash flow leverage ratio.
The Amended and Restated Credit Agreement contains customary provisions for the replacement of the LIBOR-based rate as that rate is phased out in the lending market. The Amended and Restated Credit Agreement contains customary representations, warranties, covenants and events of default, including but not limited to covenants restricting the Company’s and its subsidiaries’ ability to (i) merge or consolidate with another entity, (ii) sell, transfer, lease or convey their assets, (iii) make any material change in the nature of the core business of the Company, (iv) make certain investments, or (v) incur secured indebtedness. The Credit Agreement also requires the Company to maintain a cash flow leverage ratio of not more than 3.50 to 1.00 (unless a significant acquisition has been consummated, in which case, not more than 4.00 to 1.00 during the four fiscal quarter period beginning with the quarter in which such acquisition occurs) and an interest coverage ratio of not less than 3.00 to 1.00 (unless a significant acquisition has been consummated, in which case, not less than 2.50 to 1.00 during the four fiscal quarter period beginning with the quarter in which such acquisition occurs). A change in control of the Company will constitute an event of default under the Credit Agreement.
12.Fair Value
Assets and liabilities measured at fair value on a recurring basis and fair value measurement level were as follows (in thousands):
Level
September 24, 2021
December 25, 2020
Assets
Cash surrender value of life insurance
2
$
22,523
$
19,887
Forward exchange contracts
2
34
16
Total assets at fair value
$
22,557
$
19,903
Liabilities
Contingent consideration
3
$
11,765
$
9,454
Deferred compensation
2
5,918
5,099
Total liabilities at fair value
$
17,683
$
14,553
Contracts insuring the lives of certain employees who are eligible to participate in certain non-qualified pension and deferred compensation plans are held in trust. Cash surrender value of the contracts is based on performance measurement funds that shadow the deferral investment allocations made by participants in certain deferred compensation plans. The deferred compensation liability balances are valued based on amounts allocated by participants to the underlying performance measurement funds.
Contingent consideration liability represents the estimated value (using a probability-weighted expected return approach) of future payments to be made to previous owners of certain acquired businesses based on future revenues.
Long-term notes payable with fixed interest rates had a carrying amount of $150 million and estimated fair value of $165 million as of September 24, 2021 and estimated fair value of $170 million as of December 25, 2020. The fair value of variable rate borrowings approximates carrying value. The Company uses significant other observable inputs to estimate fair value (level 2 of the fair value hierarchy) based on the present value of future cash flows and rates that would be available for issuance of debt with similar terms and remaining maturities.
The Company supplies technology and expertise for the management of fluids and coatings in both industrial and commercial applications. It designs, manufactures and markets systems and equipment to move, measure, control, dispense and spray fluid and coating materials. Management classifies the Company’s business into three reportable segments: Industrial, Process and Contractor. Key strategies include developing and marketing new products, leveraging products and technologies into additional, growing end-user markets, expanding distribution globally and completing strategic acquisitions that provide additional channel and technologies.
The ongoing global COVID-19 pandemic and related governmental and business responses continue to have an impact on our operations, supply chains, distribution channels, and end-user customers. The timing and extent of the financial impact from the pandemic in our major geographies is still uncertain and we cannot predict the magnitude of the impact to the results of our operations or financial position. The Company has experienced raw material inflation, logistical challenges and certain component shortages. The disruptions have adversely impacted profitability in the near-term, especially within the higher volume Contractor segment. We expect these challenges to continue into 2022.
The following Management’s Discussion and Analysis reviews significant factors affecting the Company’s results of operations and financial condition. This discussion should be read in conjunction with the financial statements and the accompanying notes to the financial statements.
Consolidated Results
A summary of financial results follows (in millions except per share amounts):
Three Months Ended
Nine Months Ended
Sep 24, 2021
Sep 25, 2020
% Change
Sep 24, 2021
Sep 25, 2020
% Change
Net Sales
$
486.7
$
439.3
11
%
$
1,448.0
$
1,179.8
23
%
Operating Earnings
124.6
125.0
—
%
386.7
259.6
49
%
Operating Earnings, adjusted (1)
124.6
125.3
(1)
%
386.7
294.8
31
%
Net Earnings
103.8
114.1
(9)
%
319.6
215.8
48
%
Net Earnings, adjusted (1)
100.3
101.8
(1)
%
309.9
229.2
35
%
Diluted Net Earnings per Common Share
$
0.59
$
0.66
(11)
%
$
1.83
$
1.26
45
%
Diluted Net Earnings per Common Share, adjusted (1)
$
0.57
$
0.59
(3)
%
$
1.78
$
1.34
33
%
(1) See below for a reconciliation of adjusted non-GAAP financial measures to GAAP.
Sales increased in all regions for the quarter and year to date. Changes in currency translation rates increased worldwide sales by $6 million for the quarter and $29 million for the year to date.
Gross profit margin rate for the quarter weakened as realized pricing, increased production volume and favorable changes in currency translation rates were unable to offset higher product costs caused by supply chain and inflationary challenges. Total operating expenses for the quarter increased as a percentage of sales due to increases in sales and earnings-based expenses.
2020 results for the year to date included non-cash impairment charges of $35 million ($34 million, $0.20 per diluted share, after tax effects) related to the divestiture of a U.K.-based valve business.
Excluding the impact of the prior year impairment, excess tax benefits related to stock option exercises and certain tax provision adjustments presents a more consistent basis for comparison of financial results. A calculation of the non-GAAP measurements of adjusted income taxes, effective income tax rates, net earnings and diluted earnings per share follows (in millions except per share amounts):
The following table presents an overview of components of net earnings as a percentage of net sales:
Three Months Ended
Nine Months Ended
September 24, 2021
September 25, 2020
September 24, 2021
September 25, 2020
Net Sales
100.0
%
100.0
%
100.0
%
100.0
%
Cost of products sold
49.0
47.9
47.6
48.3
Gross Profit
51.0
52.1
52.4
51.7
Product development
4.1
4.0
4.2
4.5
Selling, marketing and distribution
13.6
12.3
13.6
13.7
General and administrative
7.8
7.3
7.9
8.7
Impairment
—
0.1
—
3.0
Operating Earnings
25.6
28.5
26.7
22.0
Interest expense
0.5
0.7
0.5
0.7
Other expense, net
0.1
0.2
—
0.5
Earnings Before Income Taxes
25.0
27.5
26.2
20.8
Income taxes
3.7
1.6
4.1
2.6
Net Earnings
21.3
%
26.0
%
22.1
%
18.3
%
Net Sales
The following table presents net sales by geographic region (in millions):
Three Months Ended
Nine Months Ended
September 24, 2021
September 25, 2020
September 24, 2021
September 25, 2020
Americas(1)
$
280.4
$
277.1
$
847.3
$
729.6
EMEA(2)
115.0
93.0
339.0
251.9
Asia Pacific
91.3
69.2
261.7
198.3
Consolidated
$
486.7
$
439.3
$
1,448.0
$
1,179.8
(1) North, South and Central America, including the United States
(2)Europe, Middle East and Africa
The following table presents the components of net sales change by geographic region:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions and Divestitures
Currency
Total
Americas
1%
0%
0%
1%
16%
0%
0%
16%
EMEA
20%
2%
2%
24%
27%
0%
8%
35%
Asia Pacific
27%
0%
5%
32%
28%
(3)%
7%
32%
Consolidated
9%
0%
2%
11%
20%
0%
3%
23%
Gross Profit
The third quarter gross profit margin rate decreased 1 percentage point from the comparable period last year as realized pricing, increased production volume and favorable changes in currency translation rates were unable to offset higher product costs caused by supply chain and inflationary challenges. For the year to date, the gross profit margin rate increased approximately 1 percentage point as realized pricing, increased production volume and favorable changes in currency translation rates offset higher product costs.
Total operating expenses for the quarter increased $20 million (19 percent) compared to the third quarter last year, including approximately $9 million (9 percentage points) of increases in sales and earnings-based expenses. Year-to-date operating expenses increased $57 million (18 percent) compared to the comparable period last year. The increase includes $28 million (9 percentage points) of increases in sales and earnings-based expenses and $5 million (2 percentage points) related to foreign currency translation.
Other Expense
Other non-operating expenses were comparable for the quarter and decreased $6 million for the year to date mostly due to favorable market valuation changes on investments held to fund certain retirement benefits liabilities.
Income Taxes
The effective income tax rate for the quarter was 15 percent, up 9 percentage points from the prior year quarter. The effective income tax rate for the year to date was 16 percent, up 4 percentage points from the comparable period last year. The increases in effective tax rates were primarily due to changes in excess tax benefits for stock option exercises and the effect of non-recurring tax benefits from other tax planning activities completed in 2020. These increases were partially offset by non-deductible impairment charges in the prior year.
Segment Results
Certain measurements of segment operations compared to last year are summarized below:
Industrial Segment
The following table presents net sales and operating earnings as a percentage of sales for the Industrial segment
(dollars in millions):
Three Months Ended
Nine Months Ended
September 24, 2021
September 25, 2020
September 24, 2021
September 25, 2020
Net Sales
Americas
$
87.2
$
76.1
$
254.3
$
209.0
EMEA
68.3
52.7
185.0
133.7
Asia Pacific
55.5
44.0
161.0
122.1
Total
$
211.0
$
172.8
$
600.3
$
464.8
Operating earnings as a percentage of net sales
35
%
35
%
35
%
32
%
The following table presents the components of net sales change by geographic region for the Industrial segment:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions
Currency
Total
Americas
14%
0%
0%
14%
21%
0%
1%
22%
EMEA
24%
3%
3%
30%
29%
2%
7%
38%
Asia Pacific
21%
0%
6%
27%
25%
0%
7%
32%
Segment Total
19%
1%
2%
22%
24%
1%
4%
29%
Sales increased in all Industrial segment regions and major end markets for the quarter and year to date. The operating margin rate for the quarter was flat compared to the prior year as higher production volume, realized pricing and favorable product and channel mix offset the impacts of higher product costs and increased sales and earnings-based expenses. For the year to date, the operating margin rate increased mostly due to higher production volume, realized pricing and expense leverage.
The following table presents net sales and operating earnings as a percentage of sales for the Process segment
(dollars in millions):
Three Months Ended
Nine Months Ended
September 24, 2021
September 25, 2020
September 24, 2021
September 25, 2020
Net Sales
Americas
$
58.5
$
52.2
$
175.0
$
153.2
EMEA
13.8
11.5
44.4
40.5
Asia Pacific
23.9
15.1
65.4
48.9
Total
$
96.2
$
78.8
$
284.8
$
242.6
Operating earnings as a percentage of net sales
22
%
21
%
23
%
19
%
The following table presents the components of net sales change by geographic region for the Process segment:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions and Divestitures
Currency
Total
Americas
11%
0%
1%
12%
14%
0%
0%
14%
EMEA
17%
0%
3%
20%
11%
(6)%
4%
9%
Asia Pacific
54%
0%
4%
58%
40%
(13)%
7%
34%
Segment Total
21%
0%
1%
22%
18%
(3)%
2%
17%
The Process segment had organic sales growth in all divisions for the quarter and year to date. Expense leverage improved the operating margin rate for the quarter. Higher production volume, the impact of divested operations and expense leverage drove the operating margin rate higher for the year to date.
Contractor Segment
The following table presents net sales and operating earnings as a percentage of sales for the Contractor segment
The following table presents the components of net sales change by geographic region for the Contractor segment:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions
Currency
Total
Americas
(10)%
0%
1%
(9)%
13%
0%
1%
14%
EMEA
12%
0%
2%
14%
33%
0%
8%
41%
Asia Pacific
14%
0%
4%
18%
21%
0%
9%
30%
Segment Total
(5)%
0%
1%
(4)%
17%
0%
2%
19%
Contractor segment sales declined in the quarter due to the effects of a successful new product offering in the prior year that did not repeat. The operating margin rate decreased 9 percentage points for the quarter and 2 percentage points for the year to date primarily due to higher product costs caused by supply chain and inflationary challenges.
Liquidity and Capital Resources
Net cash provided by operating activities of $357 million increased $95 million from the comparable period last year, mostly driven by the increase in net earnings, partially offset by increases in accounts receivable and inventories that reflect growth in business activity. Significant uses of cash in 2021 included dividend payments of $95 million, property, plant and equipment additions of $83 million and business acquisitions of $19 million. Proceeds from shares issued in 2021 totaled $40 million. Although the Company did not repurchase any shares through the third quarter of 2021, it may make opportunistic purchases going forward.
At September 24, 2021, the Company had various lines of credit totaling $595 million, of which $545 million was unused. In addition to its lines of credit, under the terms of a master note agreement with a sole lender expiring in January 2023, the Company may issue up to $200 million of senior notes. Interest on the notes will be determined at the time of issuance, at a fixed or LIBOR-based floating rate at the option of the Company, provided that the maximum aggregate principal amount of notes bearing interest at a floating rate may not exceed $100 million. Fixed rate notes issued under the agreement will mature no longer than 12 years from date of issuance and variable rate notes will mature no longer than 10 years from date of issuance.
Significant uses of cash in 2020 included purchases of Company common stock totaling $102 million, which were partially offset by net proceeds from shares issued totaling $56 million. Other significant uses of cash in 2020 included dividend payments of $88 million, property, plant and equipment additions of $46 million and business acquisitions of $28 million.
Cash balances and unused financing sources are expected to provide the Company with the flexibility to meet its liquidity needs in 2021, including its capital expenditure plan, planned dividends, share repurchases, acquisitions and operating requirements.
Outlook
For the full-year 2021, the Company continues to target mid-to-high teen sales growth on an organic, constant currency basis. Demand levels for all segments remains strong across major end markets and product categories which is expected to continue for the balance of the year.
The Company desires to take advantage of the “safe harbor” provisions regarding forward-looking statements of the Private Securities Litigation Reform Act of 1995 and is filing this Cautionary Statement in order to do so. From time to time various forms filed by our Company with the Securities and Exchange Commission, including our Form 10-K, Form 10-Qs and Form 8-Ks, and other disclosures, including our 2020 Overview report, press releases, earnings releases, analyst briefings, conference calls and other written documents or oral statements released by our Company, may contain forward-looking statements. Forward-looking statements generally use words such as “expect,” “foresee,” “anticipate,” “believe,” “project,” “should,” “estimate,” “will,” and similar expressions, and reflect our Company’s expectations concerning the future. All forecasts and projections are forward-looking statements. Forward-looking statements are based upon currently available information, but various risks and uncertainties may cause our Company’s actual results to differ
materially from those expressed in these statements. The Company undertakes no obligation to update these statements in light of new information or future events.
Future results could differ materially from those expressed due to the impact of changes in various factors. These risk factors include, but are not limited to: the impact of the COVID-19 pandemic on our business; economic conditions in the United States and other major world economies; our Company’s growth strategies, which include making acquisitions, investing in new products, expanding geographically and targeting new industries; changes in currency translation rates; the ability to meet our customers’ needs and changes in product demand; supply interruptions or delays; security breaches; new entrants who copy our products or infringe on our intellectual property; risks incident to conducting business internationally; catastrophic events; changes in laws and regulations; compliance with anti-corruption and trade laws; changes in tax rates or the adoption of new tax legislation; the possibility of asset impairments if acquired businesses do not meet performance expectations; political instability; results of and costs associated with litigation, administrative proceedings and regulatory reviews incident to our business; our ability to attract, develop and retain qualified personnel; the possibility of decline in purchases from a few large customers of the Contractor segment, variations in activity in the construction, automotive, mining and oil and natural gas industries, and the impact of declines in interest rates, asset values and investment returns on pension costs and required pension contributions. Please refer to Item 1A of our Annual Report on Form 10-K for fiscal year 2020 and Item 1A of this Form 10-Q for a more comprehensive discussion of these and other risk factors. These reports are available on the Company’s website at www.graco.com and the Securities and Exchange Commission’s website at www.sec.gov. Shareholders, potential investors and other readers are urged to consider these factors in evaluating forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.
Investors should realize that factors other than those identified above and in Item 1A might prove important to the Company’s future results. It is not possible for management to identify each and every factor that may have an impact on the Company’s operations in the future as new factors can develop from time to time.
Item 3.Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes related to market risk from the disclosures made in the Company’s 2020 Annual Report on Form 10-K.
Item 4.Controls and Procedures
Evaluation of disclosure controls and procedures
As of the end of the fiscal quarter covered by this report, the Company carried out an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures. This evaluation was done under the supervision and with the participation of the Company’s President and Chief Executive Officer and the Chief Financial Officer and Treasurer. Based upon that evaluation, the Company's President and Chief Executive Officer and the Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective.
Changes in internal controls
During the quarter, there was no change in the Company’s internal control over financial reporting that has materially affected or is reasonably likely to materially affect the Company’s internal control over financial reporting.
PART IIOTHER INFORMATION
Item 1A.Risk Factors
There have been no material changes to the Company’s risk factors from those disclosed in the Company’s 2020 Annual Report on Form 10-K.
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
On April 24, 2015, the Board of Directors authorized the Company to purchase up to 18 million shares of its outstanding common stock, primarily through open-market transactions. There were approximately 3.3 million shares remaining under the authorization on December 7, 2018, when the Board of Directors authorized the purchase of up to an additional 18 million shares. The authorizations are for an indefinite period of time or until terminated by the Board.
In addition to shares purchased under the Board authorizations, the Company purchases shares of common stock held by employees who wish to tender owned shares to satisfy the exercise price or tax due upon exercise of options or vesting of restricted stock.
Information on issuer purchases of equity securities follows:
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (at end of period)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
